Cabinet Expert Scientifique et Réglementaire
Cabinet Expert Scientifique et Réglementaire
This randomized, double-blind and placebo-controlled pilot clinical trial was conducted on 95 asymptomatic patients with COVID-19 infection receiving either 1 g of Giloy Ghanvati (Tinospora cordifolia) and 2 g of Swasari Ras (traditional herbo-mineral formulation) and 0.5 g each of …
A case report in a 44-year-old male physician who was confirmed COVID-19 positive has been recently published. He was sent for home isolation with no treatment given. The patient received a home-made TaibUVID nutritional supplement (Nigella sativa, chamomile and natural …
COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which binds to angiotensin-converting enzyme 2 (ACE2) on the cell surface and downregulates ACE2, likely elevating the ratio of angiotensin-converting enzyme (ACE) to ACE2. The overreaction of the immune …
Curcumin is proposed as a potential treatment option for coronavirus disease-19 (COVID-19). An open-label non-randomized clinical trial evaluated the efficacy of nano-curcumin oral formulation in 41 hospitalized patients with mild-moderate COVID-19. Subjects were allocated to nano-curcumin (n = 21; Sinacurcumin …
This study has evaluated the effects in silico of different lipopetides from different probiotic strains (subtilisin (Bacillus amyloliquefaciens), curvacin A (Lactobacillus curvatus), sakacin P (Lactobacillus sakei), lactococcin Gb (Lactococcus lactis)) on the inactivation of spike (S) glycoprotein of SARS-CoV-2 and …
Vitamin D is proposed as an effective solution of reducing the severity of COVID-19. Some available evidences have already reported beneficial effects of vitamin D supplementation. This new study examined the effects of vitamin D on the virus clearance. The …
This preclinical study has evaluated the potential of baicalein, an active compound of Scutellaria baicalensis, for the management of COVID-19. In vitro an inhibition of cellular damage induced by SARS-CoV-2 has been demonstrated after exposure to at least 0.1 µM …
Curcuma COVID‐19 is spreading worldwide, leading a pandemic. This review highlighted that curcumin could be a new treatment option to combat the COVID‐19. Curcumin, an active constituent of Curcuma longa (turmeric), has some useful clinical effects such as antiviral, antinociceptive, …
Viruses that cause respiratory tract infections are found in various virus families, which differ in virulence and utilize variable strategies to infect the host cells and to evade the host immune system. Among non-pharmacological solutions for the management of these …
This review is based on the correlation that has been previously reported between SRAS-CoV-2 disease progression and the composition of the gut microbiota demonstrating that some patients with COVID-19 showed intestinal microbial dysbiosis, with a decrease in cell numbers of …